Protection of natural infection against reinfection with SARS-CoV-2 JN.1 variant

Hiam Chemaitelly,Peter Coyle,Mohamed Ali Ben Kacem,Houssein H. Ayoub,Patrick Tang,Mohammad R. Hasan,Hadi M. Yassine,Asmaa A. Al Thani,Zaina Al-Kanaani,Einas Al-Kuwari,Andrew Jeremijenko,Anvar H. Kaleeckal,Ali N. Latif,Riyazuddin M. Shaik,Hanan F. Abdul-Rahim,Gheyath K. Nasrallah,Mohamed Ghaith Al-Kuwari,Adeel A. Butt,Hamad E. Al-Romaihi,Mohamed H. Al-Thani,Abdullatif Al-Khal,Roberto Bertollini,Laith J. Abu-Raddad
DOI: https://doi.org/10.1101/2024.02.22.24303193
2024-02-23
Abstract:This study investigated the effectiveness of natural infection in preventing reinfection with the JN.1 variant during a large JN.1 wave in Qatar, using a test-negative case-control study design. The overall effectiveness of previous infection in preventing reinfection with JN.1 was estimated at only 1.8% (95% CI: −9.3-12.6%). This effectiveness demonstrated a rapid decline over time since the previous infection, decreasing from 82.4% (95% CI: 40.9-94.7%) within 3 to less than 6 months after the previous infection to 50.9% (95% CI: −11.8-78.7%) in the subsequent 3 months, and further dropping to 18.3% (95% CI: −34.6-56.3%) in the subsequent 3 months. Ultimately, it reached a negligible level after one year. The findings show that the protection of natural infection against reinfection with JN.1 is strong only among those who were infected within the last 6 months, with variants such as XBB*. However, this protection wanes rapidly and is entirely lost one year after the previous infection. The findings support considerable immune evasion by JN.1.
Epidemiology
What problem does this paper attempt to address?